What is the current price of Merck & Co.?

As of Oct. 27, 2026, the latest recorded price of Merck & Co. (MRK) was 141.82 USD.

How has Merck & Co. moved recently?

Measured from closing prices: -4.37% over one week, -4.62% over one month and +65.89% over one year.

Merck & Co. (MRK): price, performance and history

AIsier's plain-language read

Written by an AI model for AIsier on the date shown, from the data listed below. It describes; it does not advise. Oct. 25, 2026

Based on: price history · long-term trend · fundamentals (13) · past events for its asset class (4) · recent news · Methodology

Merck is paying out nearly three times what it earns in profit, funded by the cash its business still generates.

What is going on right now?

The price is sitting close to where it has been over the past few weeks, without any strong push in either direction. Reported energy costs tied to oil near $116 could nudge up what Merck spends to run its plants.

How is the business itself doing?

Merck makes most of its money from prescription drugs, led by Keytruda, and vaccines. Sales grew about 5% recently, and the company produced $15.2 billion in cash from operations, but its actual reported profit is thin, with net earnings keeping only about 5 cents of every dollar sold.

What stands out?

The company's dividend currently costs about 267% of its earnings. That gap is covered by cash coming in, not by profit on paper.

What comes next?

Merck's next earnings report is scheduled for October 29, 2026, and it will show whether that widening gap between cash generation and reported profit is narrowing or growing.

Merck & Co. (MRK)

One-year price chart

Last price

Stocks